Back to Search
Start Over
Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes.
- Source :
- Heart; Jul2002, Vol. 88 Issue 1, p20-24, 5p, 6 Charts, 2 Graphs
- Publication Year :
- 2002
-
Abstract
- <bold>Background: </bold>It has been suggested that patients undergoing acute intervention for coronary syndromes may not receive adequate secondary prevention.<bold>Objective: </bold>To analyse the impact of availability and use of coronary interventions on the prescription of secondary prevention after acute coronary syndromes.<bold>Design: </bold>Analysis of a prospective multicentre register of patients admitted to hospital for acute coronary syndromes.<bold>Setting: </bold>A 1999 pan-European survey in 390 hospitals.<bold>Patients: </bold>3092 patients admitted to hospital with acute coronary syndromes (including 777 for ST elevation myocardial infarction within 12 hours of onset).<bold>Main Outcome Measures: </bold>Rates of prescription of aspirin and lipid lowering agents.<bold>Results: </bold>Performance of coronary angiography and percutaneous coronary interventions (PCI) during the hospital stay were independent predictors of prescription of aspirin at discharge (odds ratio (OR) 1.29 and 1.89, p = 0.053 and p < 0.0001, respectively). Lipid lowering agents were prescribed more often on discharge in patients admitted to hospitals with catheterisation laboratories than without (for infarction with ST elevation, 45% v 40% (NS); for other acute coronary syndromes, 46% v 36%; p < 0.05). Prescription rates were higher among patients undergoing coronary angiography or PCI than in those treated conservatively (for infarction with ST elevation, 49%, 53%, and 39%, p < 0.05; for other acute coronary syndromes, 50%, 54%, and 34%, p < 0.05). Logistic regression analysis showed that PCI was an independent predictor of prescription of lipid lowering agents at discharge (OR 1.48, p < 0.0002).<bold>Conclusions: </bold>Contrary to expectations, invasive procedures for acute coronary syndromes are associated with higher rates of prescription of pharmacological secondary prevention. [ABSTRACT FROM AUTHOR]
- Subjects :
- CORONARY heart disease treatment
ASPIRIN
ANTILIPEMIC agents
Subjects
Details
- Language :
- English
- ISSN :
- 13556037
- Volume :
- 88
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Heart
- Publication Type :
- Academic Journal
- Accession number :
- 9694151
- Full Text :
- https://doi.org/10.1136/heart.88.1.20